Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Shattuck Labs, Inc. (STTK)

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Feb 03, 2022 12:24 pm
SAN DIEGO -- 

Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons or entities who purchased or otherwise acquired Shattuck Labs, Inc. (NASDAQ: STTK) securities in connection with the Company's October 2020 initial public offering ("IPO") or between October 9, 2020 and November 9, 2021. The complaint alleges violations of the Securities Act of 1933 and Securities Exchange Act of 1934. Shattuck is a clinical-stage biotechnology company pioneering a new class of biologic medicine for the treatment of cancer and autoimmune disease.

If you suffered a loss due to Shattuck Labs, Inc.'s misconduct, click here.

Shattuck Labs, Inc. (STTK) Made False and Misleading Statements in its Offering Documents

According to the complaint, Shattuck conducted its IPO on October 9, 2020, offering approximately 13,664,704 shares at $17.00 per share. The Registration Statement in support of the IPO emphasized the importance of Shattuck's August 8, 2017 collaboration agreement with Millennium Pharmaceuticals, Inc., or Takeda, a wholly owned subsidiary of Takeda Pharmaceutical Company, Ltd. However, defendants failed to disclose that the collaboration agreement was not solid and Takeda and Shattuck would "mutually agree" to terminate the agreement in a year. As a result, Shattuck would cease to receive any future milestone, royalty, or other payments from Takeda.

On November 9, 2021, just a year after its IPO, Shattuck announced the termination of the collaboration agreement. On this news, the Company's stock price fell $5.45 per share, or 28%, to close at $13.59 per share on November 9, 2021. The stock continued to decline, and as of the date of the filing of the class action, the stock traded at just $6.13 per share.

If you purchased shares of Stattuck Labs, Inc. (STTK) in connection with the Company's October 2020 IPO or between October 9, 2020 and November 9, 2021, you have until April 1, 2022, to ask the court to appoint you lead plaintiff for the class. Contact us for more information.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
[email protected]
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Shattuck Labs, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
[email protected]
(800) 350-6003
www.robbinsllp.com

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).